Latest technology reporting
Evidence-led coverage of biotechnology, AI infrastructure, energy, robotics, devices and brain–computer interfaces.
-
Aligned’s Water-Free Air Cooler Claims More Capacity in the Same Footprint
Delta Cube 3.0 is said to improve cooling capacity and energy efficiency by 10% without increasing its footprint. The figures come from the manufacturer and still need operating evidence.
-
Samsung Says AI Memory Demand Will Outrun Supply Again in 2027
Samsung’s latest results say HBM4 sales are scaling and AI-driven memory demand will exceed industry supply by a wider margin next year. That is a company forecast, not a guaranteed shortage.
-
A $5.1 Billion Grid Loan Mixes One Gigawatt of Batteries With New Gas
The US Energy Department has closed a 30-year loan package for Alliant Energy projects in Iowa and Wisconsin. The financing is real, but individual plants and savings claims still depend on approvals and execution.
-
America’s New Battery Plan Targets the Factory Gap Between Lab and Scale
A new US Energy Department strategy and BattMan consortium focus on manufacturing, digital twins and supply chains. The roadmap sets targets, but it does not itself fund or build a battery factory.
-
FDA Proposes One Licence Framework for Many Patient-Specific Gene Edits
Draft FDA guidance would let closely related, individualized genome-editing variants sit within one biologics licence framework. It could reduce repeated development work, but it is non-binding and does not approve any therapy.
-
Invika Awakens Selected T Cells in Resistant Cancers, but Responses Remain Early
A first-in-human Phase I/II study found four partial responses among 27 people treated at the preferred biological doses. The single-arm, mixed-tumour trial is promising but far from proving a new standard of care.
-
Loading Old Mouse Bones Extended Lifespan—Without Proving an Exercise Prescription
A Cell Metabolism study links force sensing in bone cells to whole-body ageing and reports a 9.4% lifespan increase in mechanically loaded old mice. It remains a preclinical result, not a human anti-ageing treatment.
-
Tokyo’s ¥93 Billion Green Loan Turns Data-Centre Efficiency Into a Financing Test
STTGDC’s loan for a 70.8 MW Tokyo campus ties financing to building certification and a design PUE of 1.3 or better, making measurable efficiency part of the capital stack.
-
Google’s TPUs Are Leaving Google Cloud for Oracle’s Data Centres
Oracle will become the first hyperscale cloud outside Google to offer Google TPUs, a 2027 move that could weaken the link between custom AI chips and the cloud companies that designed them.
-
A $5 Billion Bet on Nuclear Uprates Could Add 1.1 Gigawatts Without New Reactors
A conditional US Energy Department loan would finance upgrades across eight Constellation nuclear sites, aiming to increase output from existing reactors rather than build a new fleet.
-
Synthetic Biology Learns to Build Organoids by Removing the Wrong Cells
Researchers programmed unwanted cells to self-destruct during the growth of lab-made liver tissue and an embryo model, introducing a “subtractive” approach to tissue engineering.
-
A Four-Patient CRISPR Trial Exposes the Delivery Problem Gene Editing Cannot Ignore
HG302 produced molecular evidence of editing and dystrophin in muscle, but a treatment-related death after systemic AAV delivery makes this first-in-human Duchenne study a safety lesson as much as a proof of activity.